1-5 of 5
Haley K. Altamura
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Lineage-specific detection of residual disease predicts relapse in patients with chronic myeloid leukemia stopping therapy

Brief Report
Ilaria S. Pagani, Naranie Shanmuganathan, Phuong Dang, Verity A. Saunders, Randall Grose, Chung H. Kok, Jane James, Molly Tolland, Jodi A. Braley, Haley K. Altamura, David T. Yeung, Susan Branford, Agnes S. M. Yong, Timothy P. Hughes, David M. Ross
Journal: Blood
Blood (2023) 142 (25): 2192–2197.
https://doi.org/10.1182/blood.2023021119
Published: 2023
Includes: Supplemental data
Journal Articles

Early BCR-ABL1 kinetics are predictive of subsequent achievement of treatment-free remission in chronic myeloid leukemia

Clinical Trials & Observations
Naranie Shanmuganathan, Ilaria S. Pagani, David M. Ross, Sahee Park, Agnes S. M. Yong, Jodi A. Braley, Haley K. Altamura, Devendra K. Hiwase, David T. Yeung, Dong-Wook Kim, Susan Branford, Timothy P. Hughes
Journal: Blood
Blood (2021) 137 (9): 1196–1207.
https://doi.org/10.1182/blood.2020005514
Published: 2021
Includes: Supplemental data
Journal Articles

The impact of multiple low-level BCR-ABL1 mutations on response to ponatinib

Clinical Trials & Observations
Wendy T. Parker, David T. O. Yeung, Alexandra L. Yeoman, Haley K. Altamura, Bronte A. Jamison, Chani R. Field, J. Graeme Hodgson, Stephanie Lustgarten, Victor M. Rivera, Timothy P. Hughes, Susan Branford
Journal: Blood
Blood (2016) 127 (15): 1870–1880.
https://doi.org/10.1182/blood-2015-09-666214
Published: 2016
Includes: Supplemental data
Journal Articles

Prognosis for patients with CML and >10% BCR-ABL1 after 3 months of imatinib depends on the rate of BCR-ABL1 decline

Clinical Trials & Observations
Susan Branford, David T. Yeung, Wendy T. Parker, Nicola D. Roberts, Leanne Purins, Jodi A. Braley, Haley K. Altamura, Alexandra L. Yeoman, Jasmina Georgievski, Bronte A. Jamison, Stuart Phillis, Zoe Donaldson, Mary Leong, Linda Fletcher, John F. Seymour, Andrew P. Grigg, David M. Ross, Timothy P. Hughes
Journal: Blood
Blood (2014) 124 (4): 511–518.
https://doi.org/10.1182/blood-2014-03-566323
Published: 2014
Includes: Supplemental data
Journal Articles

Early molecular response and female sex strongly predict stable undetectable BCR-ABL1 , the criteria for imatinib discontinuation in patients with CML

Clinical Trials & Observations
Susan Branford, David T. Yeung, David M. Ross, Jodi A. Prime, Chani R. Field, Haley K. Altamura, Alexandra L. Yeoman, Jasmina Georgievski, Bronte A. Jamison, Stuart Phillis, Brad Sullivan, Nancy E. Briggs, Mark Hertzberg, John F. Seymour, John Reynolds, Timothy P. Hughes
Journal: Blood
Blood (2013) 121 (19): 3818–3824.
https://doi.org/10.1182/blood-2012-10-462291
Published: 2013